OBJECTIVES: To identify by clinical examination, EEG, MRI, and proton spectroscopy, and neuropsychological assessment the prevalence of signs of CNS involvement in patients infected with HIV, and to relate such findings to the evidence of immunosuppression. METHODS: The design was a cross sectional analysis of a cohort of male patients with infected HIV with an AIDS defining diagnosis or low CD4 count (<350), and seropositive asymptomatic subjects, both groups being followed up in a longitudinal study. Control groups consisted of seronegative subjects from the same genitourinary medicine clinics. RESULTS: This report sets out the cross sectional findings at the seventh visit in the longitudinal study. Patients with AIDS had more signs of neurological dysfunction, poorer performance on a neuropsychological test battery, were more likely to have an abnormal EEG, and to have abnormalities on MRI. They more often had cerebral atrophy, abnormal appearing white matter, and abnormal relaxometry and spectroscopy. There was little evidence of abnormality in seropositive people who had a CD4 count >350 compared with seronegative people from a similar background. CONCLUSIONS: Detailed testing failed to disclose significant CNS impairment without immunosuppression in men infected with HIV. Findings from MRI and magnetic resonance spectroscopy (MRS) correlated with those of the neurological examination and neuropsychological assessment. A combination of such assessments offers a simple surrogate for studies of CNS involvement in HIV disease.
OBJECTIVES: To identify by clinical examination, EEG, MRI, and proton spectroscopy, and neuropsychological assessment the prevalence of signs of CNS involvement in patients infected with HIV, and to relate such findings to the evidence of immunosuppression. METHODS: The design was a cross sectional analysis of a cohort of male patients with infected HIV with an AIDS defining diagnosis or low CD4 count (<350), and seropositive asymptomatic subjects, both groups being followed up in a longitudinal study. Control groups consisted of seronegative subjects from the same genitourinary medicine clinics. RESULTS: This report sets out the cross sectional findings at the seventh visit in the longitudinal study. Patients with AIDS had more signs of neurological dysfunction, poorer performance on a neuropsychological test battery, were more likely to have an abnormal EEG, and to have abnormalities on MRI. They more often had cerebral atrophy, abnormal appearing white matter, and abnormal relaxometry and spectroscopy. There was little evidence of abnormality in seropositive people who had a CD4 count >350 compared with seronegative people from a similar background. CONCLUSIONS: Detailed testing failed to disclose significant CNS impairment without immunosuppression in men infected with HIV. Findings from MRI and magnetic resonance spectroscopy (MRS) correlated with those of the neurological examination and neuropsychological assessment. A combination of such assessments offers a simple surrogate for studies of CNS involvement in HIV disease.
Authors: H Budka; C A Wiley; P Kleihues; J Artigas; A K Asbury; E S Cho; D R Cornblath; M C Dal Canto; U DeGirolami; D Dickson Journal: Brain Pathol Date: 1991-04 Impact factor: 6.508
Authors: I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison Journal: J Neurol Neurosurg Psychiatry Date: 1997-10 Impact factor: 10.154
Authors: I D Wilkinson; R F Miller; K A Miszkiel; M N Paley; M A Hall-Craggs; T Baldeweg; I G Williams; S Carter; S P Newman; B E Kendall; J Catalan; R J Chinn; M J Harrison Journal: AIDS Date: 1997-03 Impact factor: 4.177
Authors: W K Chong; B Sweeney; I D Wilkinson; M Paley; M A Hall-Craggs; B E Kendall; J K Shepard; M Beecham; R F Miller; I V Weller Journal: Radiology Date: 1993-07 Impact factor: 11.105
Authors: M N Paley; W K Chong; I D Wilkinson; J K Shepherd; A M Clews; B J Sweeney; M A Hall-Craggs; B E Kendall; S P Newman; M J Harrison Journal: Radiology Date: 1994-03 Impact factor: 11.105
Authors: S Connolly; H Manji; R H McAllister; M Fell; C Loveday; C Kirkis; M Herns; B Sweeney; O Sartawi; P Durrance Journal: Ann Neurol Date: 1994-02 Impact factor: 10.422
Authors: Omar K Siddiqi; Melissa A Elafros; Izukanji Sikazwe; Gretchen L Birbeck; Lisa Kalungwana; Michael J Potchen; Christopher M Bositis; Igor J Koralnik; William H Theodore Journal: Neurology Date: 2015-03-04 Impact factor: 9.910
Authors: Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis Journal: J Neurovirol Date: 2006-08 Impact factor: 2.643
Authors: Ming-Chang Chiang; Rebecca A Dutton; Kiralee M Hayashi; Oscar L Lopez; Howard J Aizenstein; Arthur W Toga; James T Becker; Paul M Thompson Journal: Neuroimage Date: 2006-10-10 Impact factor: 6.556
Authors: Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma Journal: J Neurovirol Date: 2008-11-12 Impact factor: 2.643